Business
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
-- Partnership with AMI Technologies Positions FemaSeed® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions -- ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today a strategic partnership with AMI Technologies to introduce and commercialize its fertili
About this update from Femasys Inc.
[{"type":"image","alt":"Femasys Inc.","displaySize":"","headline":null,"caption":"Femasys Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":122,"url":"https://media.zenfs.com/en/globenewswire.com/301b83514d43baad2f5211eaa290a825"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2GAPMaOqvqggyHfSDG8ZUA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3MQ--/https://media.zenfs.com/en/globenewswire.com/301b83514d43baad2f5211eaa290a825","width":300,"height":122}},"lazy":false},{"type":"text","content":"-- Partnership with AMI Technologies Positions FemaSeed® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions --","length":166,"tagName":"p"},{"type":"text","content":"ATLANTA, April 16, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today a strategic partnership with AMI Technologies to introduce and commercialize its fertility portfolio in Israel. This collaboration marks an important step in the Company’s global expansion strategy and is expected to broaden international market access and drive adoption of innovative technologies, including FemaSeed as a first-line infertility treatment and FemVue® for ultrasound diagnosis of tubal factors.","length":656,"tagName":"p"},{"type":"text","content":"Israel represents a strategically important market with a strong focus on fertility care and advanced reproductive technologies. Through this partnership, Femasys is leveraging AMI Technologies’ established commercial infrastructure, deep market expertise, and longstanding relationships with healthcare providers to support efficient market entry and adoption. The collaboration is designed to accelerate physician awareness and utilization of Femasys’ innovative solutions across key fertility centers.","length":504,"tagName":"p"},{"type":"text","content":"“Our goal is to make a meaningful global impact through our important initiatives in women’s health,” said Kathy Lee-Sepsick, Founder and Chief Executive Officer of Femasys. “Israel represents an important and forward-thinking market that embraces novel technologies and seeks the latest options to optimize care. We selected AMI Technologies for their deep market exp...